ss-31 peptide clinical studies SS - SS-31 peptideside effects have protective effects on a variety of diseases Unveiling the Potential of SS-31 Peptide: A Deep Dive into Clinical Studies and Therapeutic Applications

SS-31 peptidedosing protocol The field of peptide therapeutics is rapidly evolving, with SS-31 peptide emerging as a molecule of significant interest. This mitochondria-targeting peptide, also known by its investigational drug name elamipretide, has garnered considerable attention for its potential to address a range of age-related conditions and diseases characterized by mitochondrial dysfunction. Numerous clinical studies are actively exploring the multifaceted benefits of SS-31, aiming to translate promising preclinical findings into tangible therapeutic outcomes.

At its core, SS-31 is a synthetic peptide designed to interact with the inner mitochondrial membrane. Its mechanism of action primarily involves the restoration and enhancement of mitochondrial functionEVALUATION OF THE ANTI-OXIDANT PEPTIDE, SS31 .... This is crucial because mitochondria, the powerhouses of our cells, play a vital role in energy production and cellular health.Mitochondrion-Targeted Peptide SS-31 Inhibited Oxidized ... When mitochondrial function declines, it can lead to an accumulation of cellular damage, oxidative stress, and ultimately, disease作者：S Tarantini·2018·被引用次数：206—Treatment with SS–31 significantly improved neurovascular coupling responsesby increasing NO-mediated cerebromicrovascular dilation, which was .... SS-31 demonstrates remarkable efficacy in reducing elevated levels of reactive oxygen species (ROS), a key contributor to cellular damage stemming from mitochondrial dysfunction作者：Q WANG·2024—Purpose (the aim of the study):SS-31, also known as Bendavia, is a novel peptide compound designed to target the inner mitochondrial membrane..

The therapeutic landscape for SS-31 is broad and continually expanding作者：MT Sweetwyne·2017·被引用次数：112—SS-31 treatment improved age-related mitochondrial morphology and glomerulosclerosis. Assessment of glomeruli revealed that SS-31 reduced senescence (p16, .... Current studies on SS-31 have mostly focused on cardiac disease and mitochondrial myopathy, areas where mitochondrial dysfunction is a primary driver of pathology. However, the peptide's protective effects extend far beyond these initial targets. Preclinical investigations have showcased benefits in a variety of conditions, including cognitive impairment, muscle aging, atherosclerosis, osteoarthritis, diabetes, glaucoma, and kidney-related diseases. Notably, SS31 could alleviate renal morphological and functional alterations, suggesting a significant role in renal health.

The journey of SS-31 from laboratory research to potential clinical application is underscored by ongoing clinical trials. These trials are designed to rigorously assess the safety and efficacy of SS-31 in human subjects. While some clinical trials are still in their early phases, others have progressed to more advanced stages. For instance, SS-31 treatment improved age-related mitochondrial morphology and glomerulosclerosis, highlighting its potential in age-related kidney conditions(PDF) The effects of a mitochondrial targeted peptide .... Furthermore, clinical trials are underway for SS31, which is showing potential in managing mitochondrial myopathies and Barth syndrome. Barth syndrome, a rare genetic disorder, is one area where elamipretide has been tested in an American clinical trial as a potential first therapy for BTHS patientsPreclinical studies showed benefit in cognitive impairment, muscle aging, atherosclerosis, osteoarthritis, diabetes, glaucoma, etc., butclinical trialsin ....

Beyond these specific conditions, clinical trials with SS-31 have reported promising results in age-related conditions including heart failure, muscle weakness, chronic kidney disease and age-related macular degeneration作者：Y Hou·2018·被引用次数：59—Our recent study demonstrated thatSS31 could alleviate renal morphological and functional alterations, inhibit renal cell apoptosis and .... The peptide's ability to reverse age-related deficits is a significant finding.Thus, SS31 and mitoTEMPOhave protective effects on a variety of diseases, including heart and kidney-related diseases, as well as sepsis and diabetes, which ... Treatment with SS-31 rapidly reverses in vivo deficits in mitochondrial energetics in aged skeletal muscle and improves skeletal muscle function.2026年1月2日—Clinically Validated — Extensive research andclinical trialsdemonstrateSS-31'ssafety profile and therapeutic efficacy for cardiovascular ... This rejuvenation of cellular energy production holds immense promise for combating the debilitating effects of aging作者：S Hao·2015·被引用次数：54—SS-31provides a beneficial effect on macrophagesfrom foam cell formation, likely, through both ROS scavenging and inhibition of cholesterol influx..

The scientific exploration of SS-31 is not limited to its direct therapeutic effects. Researchers are also investigating novel SS-31 derived peptides to further optimize its properties and expand its therapeutic reachSS31. For example, nineteen SS-31 derived peptides have been explored in the context of neurodegenerative diseases, indicating a proactive effort to refine the peptide's structure for enhanced efficacy.EVALUATION OF THE ANTI-OXIDANT PEPTIDE, SS31 ...

The impact of SS-31 on cellular processes is profound. It has been shown to improve mitochondrial energetics, enhance neurovascular coupling responses by increasing NO-mediated cerebromicrovascular dilation, and protect against oxidative stressTreatment with the mitochondrial‐targeted antioxidant .... SS31 treatment effectively enhanced the recovery of skeletal muscle function, alleviated skeletal muscle injury and suppressed mitochondrial ROS production. Its protective role extends to various cell types, as evidenced by findings that SS31 can protect human lens epithelial cells by reducing oxidative stress.

Moreover, SS-31 emerges as a promising therapeutic candidate to attenuate neurodegeneration pertinent to alpha-synuclein misfolding and aggregation. This positions it as a potential treatment for conditions like Parkinson's disease.作者：M Li·2024·被引用次数：11—Exploring novel SS-31 derivatives is important for the treatment of neurodegenerative diseases. In this study,nineteen SS-31 derived peptides( ... The peptide also provides a beneficial effect on macrophages from foam cell formation, likely through both ROS scavenging and inhibition of cholesterol influx, suggesting a role in cardiovascular health by mitigating atherosclerosis.

The designation of SS-31 as a potential therapeutic agent is further solidified by its recognition as a drug candidate for rare mitochondrial disorders. The extensive research and clinical trials demonstrating SS-31's safety profile and therapeutic efficacy for cardiovascular conditions, among others, are a testament to its growing importance. While there may not be an immediately available effective treatment for all clinical cases of certain conditions, the ongoing development of SS-31 offers a beacon of hope.作者：Q WANG·2024—Purpose (the aim of the study):SS-31, also known as Bendavia, is a novel peptide compound designed to target the inner mitochondrial membrane.

In summary, the SS-31 peptide represents a significant advancement in the development of targeted therapies for a wide array of diseases. The robust body of clinical studies and ongoing research continues to unveil its remarkable potential to restore mitochondrial function, combat oxidative stress, and improve cellular health across various organ systems. As clinical trials progress, the therapeutic applications of SS-31, also known as elamipretide and Bendavia, are poised to expand, offering new avenues for treating age-related diseases and other debilitating conditions2022年5月27日—Preliminary studies in the treatment of diseases in ophthalmology have shown thatSS31 can protect human lens epithelial cellsby reducing .... The exploration of peptide SS and its various forms, including 31's unique properties, is a dynamic area of scientific inquiry with profound implications for human health.